Vagal stimulation for heart failure

Current Opinion in Cardiology

Volumn 26, Issue 1, 2011, Pages 51-54

  Schwartz, Peter J ^a,b,c,d,e  

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

^e KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Autonomic nervous system; Heart failure; Vagal stimulation

Indexed keywords

ARTICLE; CARDIOVASCULAR RISK; HEART FAILURE; HEART RATE; HUMAN; NONHUMAN; PRIORITY JOURNAL; VAGUS NERVE STIMULATION;

ANIMALS; DOGS; HEART FAILURE; HUMANS; RATS; VAGUS NERVE STIMULATION;

EID: 79951673361     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/HCO.0b013e3283413961     Document Type: Article

References (20)

1. Schwartz PJ, De Ferrari GM. Sympathetic-parasympathetic interaction in health and disease: abnormalities and relevance in heart failure. Heart Fail Rev 2011. [Epub ahead of print]
2. Schwartz PJ, Vanoli E, Stramba-Badiale M, et al. Autonomic mechanisms and sudden death. New insights from analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction. Circulation 1988; 78:969-979.
3. La Rovere MT, Bigger JT Jr, Marcus FI, et al., for the ATRAMI Investigators. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. Lancet 1998; 351:478-484. (Pubitemid 28070094)
4. La Rovere MT, Pinna GD, Hohnloser SH, et al., on behalf of the ATRAMI Investigators. Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias. Implications for clinical trials. Circulation 2001; 103:2072-2077. (Pubitemid 32373010)
5. De Ferrari GM, Sanzo A, Bertoletti A, et al. Baroreflex sensitivity predicts longterm cardiovascular mortality after myocardial infarction even in patients with preserved left ventricular function. J Am Coll Cardiol 2007; 50:2285-2290. (Pubitemid 350192103)
6. Mortara A, La Rovere MT, Pinna GD, et al. Arterial baroreflex modulation of heart rate in chronic heart failure: clinical and hemodynamic correlates and prognostic implications. Circulation 1997; 96:3450-3458. (Pubitemid 27513419)
7. La Rovere MT, Pinna GD, Maestri R, et al. Prognostic implications of baroreflex sensitivity in heart failure patients in the beta-blocking era. J Am Coll Cardiol 2009; 53:193-199.
8. Adamson PB, Smith AL, Abraham WT, et al., InSync III Model 8042 and Attain OTW Lead Model 4193 Clinical Trial Investigators. Continuous autonomic assessment in patients with symptomatic heart failure: prognostic value of heart rate variability measured by an implanted cardiac resynchronization device. Circulation 2004; 110:2389-2394. (Pubitemid 39407344)
9. Vanoli E, De Ferrari GM, Stramba-Badiale M, et al. Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction. Circ Res 1991; 68:1471-1481.
10. Li M, Zheng C, Sato T, et al. Vagal nerve stimulation markedly improves longterm survival after chronic heart failure in rats. Circulation 2004; 109:120-124. (Pubitemid 38056032)
11. Sabbah HN, Rastogi S, Mishra S, et al. Long-term therapy with neuroselective electric vagus nerve stimulation improves LV function and attenuates global LV remodelling in dogs with chronic heart failure [abstract]. Eur J Heart Fail 2005; 4 (Suppl):166-167.
12. Zhang Y, Popovic ZB, Bibevski S, et al. Chronic vagus nerve stimulation improves autonomic control and attenuates systemic inflammation and heart failure progression in a canine high-rate pacing model. Circ Heart Fail 2009; 2:692-699.
13. Uthman BM, Reichl AM, Dean JC, et al. Effectiveness of vagus nerve stimulation in epilepsy patients, a 12-year observation. Neurology 2004; 63:1124-1126. (Pubitemid 39287934)
14. Shuchman M. Approving the vagus-nerve stimulator for depression. N Engl J Med 2007; 356:1604-1607. (Pubitemid 46631669)
15. Schwartz PJ, De Ferrari GM, Sanzo A, et al. Long term vagal stimulation in patients with advanced heart failure: first experience in man. Eur J Heart Fail 2008; 10:884-891.
16. De Ferrari GM, Crijns HJGM, Borggrefe M, et al.; for the CardioFit Multicenter Trial Investigators. Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure. Eur Heart J (in press).
17. Schwartz PJ, Billman GE, Stone HL. Autonomic mechanisms in ventricular fibrillation induced by myocardial ischemia during exercise in dogs with healed myocardial infarction. An experimental preparation for sudden cardiac death. Circulation 1984; 69:790-800. (Pubitemid 14125661)
18. Sabbah HN, Imai M, Zaretsky A, et al. Therapy with vagus nerve electrical stimulation combined with beta-blockade improves left ventricular systolic function in dogs with heart failure beyond that seen with beta-blockade alone [abstract]. Eur J Heart Fail 2007; 6 (Suppl 1):114.
19. Sabbah HN, Wang M, Jiang A, et al. Right vagus nerve stimulation improves left ventricular function in dogs with heart failure [abstract]. J Am Coll Cardiol 2010; 55 (Suppl A):A16-E151.
20. De Ferrari GM, Schwartz PJ. Vagus nerve stimulation: from preclinical to clinical application - challenges and future directions. Heart Fail Rev 2011 (in press).